Michelle Knowlen’s Post

Want to share your research, insights, and talents in the field of chemistry and environmental toxicology? Care about context? The PNW Chapter of SETAC just opened its abstract submission form for this year's annual conference. We are excited to announce this year's theme: Bridging the Past and Shaping the Future: Solutions from Science The conference is May 13-15th in Troutdale, Oregon. https://lnkd.in/gj_9ipqt #chemistry #environmental Toxicology #PNW #SETAC #sustainability #pollution #health #salmon #solutions.

Learn from our experts in this published whitepaper focused on the benefits of pharmaceutical #QualityByDesign and considerations for drug-device #CombinationProducts and partnerships. https://bit.ly/2DgwobB

In today’s #ToxBlog I talk briefly about the recent American Bar Association (ABA) resolution, which supports the promotion, development and use of methods to reduce, replace and refine animal models, and its implications on the future of replacement alternatives. The resolution serves to further pave the way for replacement alternatives in the fields of biomedical and health science.  Thanks to the ABA member groups that supported this resolution, including the Animal Law Committee, the Science and Technology Law section, and the International Law section.

What kind of society do we wish to become?

On this last day of Black History Month 2024, I want to thank @samford_snpha for this amazing reel on the work of A² Pharmacy Solutions and the black pharmacy experience. They asked some great questions! Press play to see my responses▶️ If you haven’t already, please take a moment to follow @a2pharmacysolutions and @samford_snpha on Instagram. #a2ps #a2pharmacysolutions #doctorlany #yourfavoritepharmacist #harddrugnames #pharmacytings #pharmacymyway #pharmacy #pharmacists #pharmacybasedclinic #healthequity #healthequitynow #healthequityadvocate

Enhancing patient diversity in clinical trials is a priority in drug development. Groups such as women, pediatric and elderly patients, people with disabilities, LGBTQ+ individuals and racial/ethnic minorities are often excluded from trials. As a result, the U.S. government has taken increased measures to require sponsors to submit diversity plans. Learn more: #DiversityInClinicalTrials #InclusiveResearch #PatientCare

Enhancing patient diversity in clinical trials is a priority in drug development. Groups such as women, pediatric and elderly patients, people with disabilities, LGBTQ+ individuals and racial/ethnic minorities are often excluded from trials. As a result, the U.S. government has taken increased measures to require sponsors to submit diversity plans. Learn more: #DiversityInClinicalTrials #InclusiveResearch #PatientCare

Enhancing patient diversity in clinical trials is a priority in drug development. Groups such as women, pediatric and elderly patients, people with disabilities, LGBTQ+ individuals and racial/ethnic minorities are often excluded from trials. As a result, the U.S. government has taken increased measures to require sponsors to submit diversity plans. Learn more: #DiversityInClinicalTrials #InclusiveResearch #PatientCare

Enhancing patient diversity in clinical trials is a priority in drug development. Groups such as women, pediatric and elderly patients, people with disabilities, LGBTQ+ individuals and racial/ethnic minorities are often excluded from trials. As a result, the U.S. government has taken increased measures to require sponsors to submit diversity plans. Learn more: #DiversityInClinicalTrials #InclusiveResearch #PatientCare

📑 Dive into the essentials of transport risk assessment and verification with Cencora's latest whitepaper! Explore how Cencora PharmaLex navigates regulatory requirements, ensuring medicinal products maintain quality and integrity throughout transportation. Learn how our insights bridge theory with practice, ensuring compliance and product safety. Stay informed and stay compliant with Cencora PharmaLex. #TransportRiskAssessment #QualityRiskManagement #CencoraPharmaLex #EUPharma24 #GenerisEPOS Transport Risk Assessment and Verification (https://hubs.ly/Q02xYWv50)